Polydendritic Nano-Adjuvant
Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.
Polydendritic Nano-Adjuvant Read More »
Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.
Polydendritic Nano-Adjuvant Read More »